While many patients report benefits with these approaches, long-term research remains more robust for standard dosing protocols
IONIS-GCGR Rx, a drug targeting GCGR, is currently in Phase II clinical trials 7
Other weight loss medications will have an effectiveness of a 5% to 9% weight reduction, while GLP-1 agonist medications can show a 15% to even 20% loss, which is comparable to gastric bypass. What should someone who wants to try this treatment know about it
The practical impact is concerning: Some women have reported unexpected pregnancies while on the pill and GLP-1s together
Even some FDA-approved medications for weight loss, like Wegovy and Zepbound, have had limited coverage
Important Notice This product is intended for laboratory and research use only